Tag: Atrial Fibrillation
Risk for Atrial Fibrillation Recurrence Increases With Body Weight
Body mass index linked to both short- and long-term risk for return of the heart rhythm disorder following ablation
A-Fib Detected in Nearly Three in 10 Cryptogenic Stroke Patients
Most patients diagnosed with AF were asymptomatic; arrhythmia detected with 12 months of continuous cardiac monitoring
NOACs May Be Better Choice for Patients With A-Fib and DM
Risks for diabetes complications, mortality lower with non-vitamin K antagonist oral anticoagulants versus warfarin
USPSTF: Evidence Still Lacking for Atrial Fibrillation Screening
Evidence currently inadequate for assessing the balance of benefits and harms of screening for atrial fibrillation in asymptomatic adults
Frail Patients With Nonvalvular A-Fib Less Likely to Receive Anticoagulants
Frail patients with nonvalvular atrial fibrillation also less likely to receive a direct oral anticoagulant versus warfarin
AI-Based Analysis of ECG May Help Assess A-Fib Risk
Predictive utility comparable for CHARGE AF clinical risk score, artificial intelligence-enabled analysis of 12-lead electrocardiogram
Incidence of Atrial Fibrillation Up After Breast Cancer Diagnosis
Breast cancer stage strongly linked to development of AF; new-onset AF after breast cancer diagnosis linked to increased cardiovascular mortality
Diabetes Patients Less Often Perceive Atrial Fibrillation Symptoms
Those with diabetes and a-fib have worse quality of life and more cardiac and neurological morbidities than those without diabetes
Screening Seniors for A-Fib Reduces Risk for Adverse Outcomes
Reduction seen in combined end point of stroke, systemic embolism, bleeding leading to hospitalization, death
Individual A-Fib Episodes Tied to Recent Alcohol Intake
AF episodes also linked to higher odds of peak blood alcohol concentration, total area under curve of alcohol exposure
